PARADIGM-HF Trial

A new class of drug (Neprilysin inhibitor ) when combined with angiotensin receptor blocker , has been shown to be better than Enalapril. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure — NEJM.

%d bloggers like this: